Brief: Bergenbio Teams With Tempus For STK11M Development
20/08/2024 06:10
Aug 20 (Reuters) - Bergenbio ASA BGBIO.OL :
* BERGENBIO COLLABORATES WITH TEMPUS TO POTENTIALLY
ACCELERATE
DEVELOPMENT IN STK11M NON-SMALL CELL LUNG CANCER
* BGBC016 TRIAL TO ASSESS BEMCENTINIB IN 1L STK11M PATIENTS
Source text for Eikon: ID:nWkr18R28d
Further company coverage: BGBIO.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Oncoinvent ASA
See all newsBrief: Oncoinvent To Raise Up To NOK 140 Million In Private Placement
Brief: Oncoinvent H1 Operating Loss NOK 69 Mln
Brief: Oncoinvent Secures New Patent Expanding Protection For Radspherin
Brief: Oncoinvent's Shares To Be Consolidated In Ratio Of 100:1
Brief: Oncoinvent To Increase Share Capital In Connection With Settlement Of Underwriting Fee